The Effect of Angiotensin Receptor-Neprilysin Inhibitor With Sodium-Glucose Cotransporter 2 Inhibitor versus Angiotensin Receptor-Neprilysin Inhibitor Without Sodium-Glucose Cotransporter 2 Inhibitor on Heart Failure Outcomes in Patients With Heart Failure With Reduced Ejection Fraction

被引：0
作者：
Kommu, Sharath
机构：
来源：
CIRCULATION | 2023年 / 148卷
关键词：
Heart Failure; Angiotensin-Receptor Neprilysin Inhibitor (ARNI); Outcomes; Ejection fraction; Cardioprotective drugs;
D O I：
10.1161/circ.148.suppl_1.12247
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A12247
引用
收藏
页数：2
相关论文
共 50 条
[31]   Sodium-glucose cotransporter 2 inhibitor-induced euglycaemic diabetic ketoacidosis in heart failure with preserved ejection fraction [J].
Cavka, Luka ;
Bencak Ferko, Urska ;
Pitz, Natasa ;
Trpkovski, Zoranco ;
Lainscak, Mitja .
ESC HEART FAILURE, 2021, 8 (04) :2631-2636
[32]   Effects of angiotensin receptor-neprilysin inhibitor on ketone body metabolism in pre-heart failure/heart failure patients [J].
Kashiwagi, Yusuke ;
Nagoshi, Tomohisa ;
Tanaka, Yoshiro ;
Oi, Yuhei ;
Kimura, Haruka ;
Ogawa, Kazuo ;
Kawai, Makoto ;
Yoshimura, Michihiro .
SCIENTIFIC REPORTS, 2024, 14 (01)
[33]   Shift of conventional paradigm of heart failure treatment: from angiotensin receptor neprilysin inhibitor to sodium-glucose co-transporter 2 inhibitors? [J].
Berezin, Alexander E. ;
Berezin, Alexander A. .
FUTURE CARDIOLOGY, 2020, 17 (03) :497-506
[34]   Clinical outcomes in heart failure patients with and without atrial fibrillation receiving sodium-glucose cotransporter-2 inhibitor [J].
Wei-Syun Hu ;
Cheng-Li Lin .
Naunyn-Schmiedeberg's Archives of Pharmacology, 2023, 396 :1977-1986
[35]   Clinical outcomes in heart failure patients with and without atrial fibrillation receiving sodium-glucose cotransporter-2 inhibitor [J].
Hu, Wei-Syun ;
Lin, Cheng-Li .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2023, 396 (09) :1977-1986
[36]   Angiotensin receptor-neprilysin inhibitors: A new paradigm in heart failure with reduced ejection fraction [J].
Docherty, Kieran F. ;
McMurray, John J. V. .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2019, 281 :179-185
[37]   Sodium-glucose cotransporter 2 inhibitor effects on heart failure hospitalization and cardiac function: systematic review [J].
Rasalam, Roy ;
Atherton, John J. ;
Deed, Gary ;
Molloy-Bland, Michael ;
Cohen, Neale ;
Sindone, Andrew .
ESC HEART FAILURE, 2021, 8 (05) :4093-4118
[38]   Effect of Sodium-glucose Cotransporter 2 Inhibitor on Vascular Endothelial Function and Diastolic Function in Patients With Heart Failure With Preserved Ejection Fraction (hfpef) [J].
Sakai, Takaaki ;
Miura, Shinichiro .
CIRCULATION, 2017, 136
[39]   Use of Sodium-Glucose Cotransporter-2 Inhibitors and Angiotensin Receptor-Neprilysin Inhibitors in Patients With Atrial Fibrillation and Heart Failure From 2021 to 2022: An Analysis of Real-World Data [J].
Alonso, Alvaro ;
Morris, Alanna A. ;
Naimi, Ashley I. ;
Alam, Aniqa B. ;
Li, Linzi ;
Subramanya, Vinita ;
Chen, Lin Yee ;
Lutsey, Pamela L. .
JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2024, 13 (06)
[40]   Sodium-glucose cotransporter 2 inhibitor may not prevent atrial fibrillation in patients with heart failure: a systematic review [J].
Ouyang, Xiaolan ;
Wang, Jiafu ;
Chen, Qian ;
Peng, Long ;
Li, Suhua ;
Tang, Xixiang .
CARDIOVASCULAR DIABETOLOGY, 2023, 22 (01)
12345